Category: Neuropathy

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) in Combination With Inlyta® (axitinib) as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma (RCC)

KENILWORTH, N.J.–(BUSINESS WIRE)–Apr 22, 2019–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with Inlyta (axitinib), a tyrosine kinase inhibitor,...

Intravenous Immunoglobulin Market Outlook, Industry Top Manufactures, Market Size, Growth Analysis & Forecast to 2028

Intravenous Immunoglobulin market Global Intravenous Immunoglobulin Market research report offers an expert and exhaustive analysis of the present condition close by competitive scenario, Intravenous Immunoglobulin Market share and forecast by 2028. The report introduces the essentials: characterizations, definitions, applications and Intravenous...